Cogent Biosciences (COGT) Common Equity (2017 - 2026)
Cogent Biosciences' Common Equity was $532.39 million in Q2 2026, up 243.4% from $155.04 million a year earlier but down 12.4% from the prior quarter.
Cogent Biosciences (COGT) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Cogent Biosciences came in at $636.37 million, up 148.3% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
- In earlier years, Common Equity was $256.29 million in FY2024 (-0.6%), $257.8 million in FY2023 (+0.8%), $255.74 million in FY2022 (+19.4%) and $214.18 million in FY2021 (-8.7%).
- Quarterly Common Equity has moved between $155.04 million (Q2 2025) and $636.37 million (Q4 2025) over five years.
- Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 57.8% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q2 2026 (growth of 243.4%); the worst was Q2 2025 (a decline of 58.5%).
- Per Business Quant data, COGT's Common Equity in the three quarters before Q2 2026 was $607.69 million (Q1 2026), $636.37 million (Q4 2025) and $302.46 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Cogent Biosciences | 5.50 Bn | 2.15 Bn | - | 516.26 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 516.26 Mn |
| Jun 30, 2026 | 532.39 Mn |
| Mar 31, 2026 | 607.69 Mn |
| Dec 31, 2025 | 636.37 Mn |
| Sep 30, 2025 | 302.46 Mn |
| Jun 30, 2025 | 155.04 Mn |
| Mar 31, 2025 | 219.00 Mn |
| Dec 31, 2024 | 256.29 Mn |
| Sep 30, 2024 | 314.66 Mn |
| Jun 30, 2024 | 373.22 Mn |
| Mar 31, 2024 | 422.33 Mn |
| Dec 31, 2023 | 257.80 Mn |
| Sep 30, 2023 | 302.90 Mn |
| Jun 30, 2023 | 348.43 Mn |
| Mar 31, 2023 | 223.56 Mn |
| Dec 31, 2022 | 255.74 Mn |
| Sep 30, 2022 | 289.94 Mn |
| Jun 30, 2022 | 319.39 Mn |
| Mar 31, 2022 | 187.86 Mn |
| Dec 31, 2021 | 214.18 Mn |
Cogent Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=COGT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "COGT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=COGT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();